0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
About This Journal |

Additional Information FREE

JAMA. 2006;295(11):E7-E14. doi:10.1001/jama.295.11.E7.
Text Size: A A A
Published online

eTable 2 Non–Late-Breaking Trials Included in This Study

eTable 2 Non–Late-Breaking Trials Included in This Study (cont)

eTable 2 Non–Late-Breaking Trials Included in This Study (cont)

Table Graphic Jump LocationeTable 2. Non–Late-Breaking Trials Included in This Study

Table Graphic Jump LocationeTable 2. Non–Late-Breaking Trials Included in This Study (cont)

Table Graphic Jump LocationeTable 2. Non–Late-Breaking Trials Included in This Study (cont)
Bech GJW, De Bruyne B, Pijls NHJ.  et al.  Fractional flow reserve to determine the appropriateness of angioplasty in moderate coronary stenosis: a randomized trial.  Circulation. 2001;103:2928-2934
PubMed   |  Link to Article
Bettendorf M, Schmidt KG, Grulich-Henn J.  et al.  Tri-iodothyronine treatment in children after cardiac surgery: a double-blind, randomised, placebo-controlled study.  Lancet. 2000;356:529-534
PubMed   |  Link to Article
Boden WE, van Gilst WH, Scheldewaert RG.  et al.  Diltiazem in acute myocardial infarction treated with thrombolytic agents: a randomized placebo-controlled trial.  Lancet. 2000;355:1751-1756
PubMed   |  Link to Article
Davidson CJ, Laskey WK, Hermiller JB.  et al.  Randomized trial of contrast media utilization in high-risk PTCA: the COURT trial.  Circulation. 2000;101:2172-2177
PubMed   |  Link to Article
Henkin Y, Shai I, Zuk R.  et al.  Dietary treatment of hypercholesterolemia: do dietitians do it better? a randomized, controlled trial.  Am J Med. 2000;109:549-555
PubMed   |  Link to Article
Henry TD, Annex BH, McKendall GR.  et al.  The VIVA trial: vascular endothelial growth factor in ischemia for vascular angiogenesis.  Circulation. 2003;107:1359-1365
PubMed   |  Link to Article
Hulley S, Grady D, Bush T.  et al.  Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women.  JAMA. 1998;280:605-613
PubMed   |  Link to Article
Izumi M, Tsuchikane E, Funamoto M.  et al.  Final results of the CAPAS trial.  Am Heart J. 2001;142:782-789
PubMed   |  Link to Article
Lee JK, Klein GJ, Krahn AD.  et al.  Rate-control versus conversion strategy in postoperative atrial fibrillation: a prospective, randomized pilot study.  Am Heart J. 2000;140:871-877
PubMed   |  Link to Article
Lotan C, Rozenman Y, Hendler A.  et al.  Stents in total occlusion for restenosis prevention: the multicentre randomized STOP study.  Eur Heart J. 2000;21:1960-1966
PubMed   |  Link to Article
Mahaffey KW, Harrington RA, Simoons ML.  et al.  Stroke in patients with acute coronary syndromes: incidence and outcomes in the platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial.  Circulation. 1999;99:2371-2377
PubMed   |  Link to Article
Maresta A, Balduccelli M, Varani E.  et al.  Prevention of postcoronary angioplasty restenosis by omega-3 fatty acids: main results of the espent for prevention of restentonsis Italian study (ESPRIT).  Am Heart J. 2002;143:e5
PubMed   |  Link to Article
Oesterle SN, Sanborn TA, Ali N.  et al.  Percutaneous transmyocardial laser revascularisation for severe angina: the PACIFIC randomised trial.  Lancet. 2000;356:1705-1710
PubMed   |  Link to Article
Kastrati A, Schomig A, Dirschinger J.  et al.  Increased risk of restenosis after placement of gold-coated stents: results of a randomized trial comparing gold-coated with uncoated steel stents in patients with coronary artery disease.  Circulation. 2000;101:2478-2483
PubMed   |  Link to Article
Stone GW, Moliterno DJ, Bertrand M.  et al.  Impact of clinical syndrome acuity on the differential response to 2 glycoprotein IIb/IIIa inhibitors in patients undergoing coronary stenting: the TARGET trial.  Circulation. 2002;105:2347-2354
PubMed   |  Link to Article
Vetrano A, Milani M, Corsini G. Effects of aspirin or picotamide, an antithromboxane agent, in combination with low-intensity oral anticoagulation in patients with acute myocardial infarction: a controlled randomized pilot trial.  G Ital Cardiol. 1999;29:524-528
PubMed
Anselme F, Savoure A, Cribier A.  et al.  Catheter ablation of typical atrial flutter: a randomized comparison of two methods for determining complete bidirectional isthmus block.  Circulation. 2001;103:1434-1439
PubMed   |  Link to Article
Brito FS, Caixeta AM, Perin MA.  et al.  Comparison of direct stenting versus stenting with predilation for the treatment of selected coronary narrowings.  Am J Cardiol. 2002;89:115-120
PubMed   |  Link to Article
Pedersen OD, Bagger H, Keller N.  et al.  Efficacy of dofetilide in the treatment of atrial fibrillation-flutter in patients with reduced left ventricular function.  Circulation. 2001;104:292-296
PubMed   |  Link to Article
Villani GQ, Piepoli MF, Terracciano C.  et al.  Effects of diltiazem pretreatments on direct-current cardioversion in patients with persistent atrial fibrillation: a single blind, randomized, controlled study.  Am Heart J. 2000;140:e12
Link to Article
Andrews TC, Ballantyne CM, Hsia JA.  et al.  Achieving and maintaining national cholesterol education program low-density lipoprotein cholesterol goals with five statins.  Am J Med. 2001;111:185-191
PubMed   |  Link to Article
Fiore LD, Ezekowitz MD, Brophy MT.  et al.  A randomized trial of transfer for primary angioplasty versus on-site thrombolysis in patients with high-risk myocardial infarction: primary results of the CHAMP study.  Circulation. 2002;105:557-563
PubMed   |  Link to Article
Grines CL, Westerhausen DR, Grines LL.  et al.  A randomized trial of transfer for primary angioplasty versus on-site thrombolysis in patients with high-risk myocardial infarction: the air primary angioplasty in myocardial infarction study.  J Am Coll Cardiol. 2002;39:1713-1719
PubMed   |  Link to Article
Gulielmos V, Menschikowski M, Dill H-M.  et al.  Interleukin 1, interleukin 6 and myocardial enzyme response after coronary artery bypass grafting—a prospective randomized comparison of the conventional and three minimally invasive surgical techniques.  Eur J Cardiothorac Surg. 2000;18:594-601
PubMed   |  Link to Article
Hall R, Chong C. A double-blind, parallel-group study of amlodipine versus long-acting nitrate in the management of elderly patients with stable angina.  Cardiology. 2001;96:72-77
PubMed   |  Link to Article
Peters RJG, Spickler W, Theroux P.  et al.  Randomized comparison of a novel anticoagulant, vasoflux, and heparin as adjunctive therapy to streptokinase for acute myocardial infarction: results of the VITAL study (vasoflux international trial for acute myocardial infarction lysis).  Am Heart J. 2001;142:237-243
PubMed   |  Link to Article
Reis SE, Costantino JP, Wickerham DL.  et al.  Cardiovascular effects of tamoxifen in women with and without heart disease: breast cancer prevention trial.  J Natl Cancer Inst. 2001;93:16-21
PubMed   |  Link to Article
Schuchert A, Meinertz T. A randomized study on the effects of pacemaker programming to a lower output on projected pulse generator longevity.  Pacing Clin Electrophysiol. 2001;24:1234-1239
PubMed   |  Link to Article
Sick PB, Thiele H, Brosteanu O.  et al.  Prospective randomized comparison of early and late results of 4 different stent designs.  Am Heart J. 2003;146:134-141
PubMed   |  Link to Article
Hochman JS, Buller CE, Sleeper LA.  et al.  Cardiogenic shock complicating acute myocardial infarction-etiologies, management and outcome: a report from the SHOCK trial registry.  J Am Coll Cardiol. 2000;36:1063-1070
PubMed   |  Link to Article
Tardif JC, Mercier LA, Theroux P.  et al.  Effect of inhibition of the NA+/H+ exchanger with cariporide on left ventricular function in acute coronary syndromes: results from the echocardiographic substudy of the GUARDIAN trial.  Can J Cardiol. 2004;20:317-322
PubMed
Attie F, Rosas M, Granados N.  et al.  Surgical treatment for secundum atrial septal defects in patients > 40 years old: a randomized clinical trial.  J Am Coll Cardiol. 2001;38:2035-2042
PubMed   |  Link to Article
Bech GJ, De Bruyne B, Pijls NHJ.  et al.  Fractional flow reserve to determine the appropriateness of angioplasty in moderate coronary stenosis: a randomized trial.  Circulation. 2001;103:2928-2934
PubMed   |  Link to Article
Berlowitz MS, Latif F, Hankins SR.  et al.  Dose-dependent blockade of the angiotensin II type 1 receptor with losartan in normal volunteers.  J Cardiovasc Pharmacol. 2001;37:692-696
PubMed   |  Link to Article
Brofferio A, Alaeddini J, Oommen R.  et al.  Effect of early administration of atropine on paradoxical sinus deceleration during dobutamine stress echocardiography.  Am J Cardiol. 2002;89:645-647
PubMed   |  Link to Article
Brouwer MA, van den Bergh PJ, Aengevaeren WR.  et al.  Aspirin plus coumarin versus aspirin alone in the prevention of reocclusion after fibrinolysis for acute myocardial infarction: results of the antithrombotics in the prevention of reocclusion in coronary thrombolysis (APRICOT)-2 trial.  Circulation. 2002;106:659-665
PubMed   |  Link to Article
Desmet WJ, Dens J, Coussement P.  et al.  Does adenosine prevent myocardial micronecrosis following percutaneous coronary intervention? the ADELINE pilot trial.  Heart. 2002;88:293-295
PubMed   |  Link to Article
Grines CL, Cox DA, Stone GW.  et al.  Coronary angioplasty with or without stent implantation for acute myocardial infarction.  N Engl J Med. 1999;341:1949-1956
PubMed   |  Link to Article
Grundy SM, Vega GL, McGovern ME.  et al.  Efficacy, safety, and tolerability of once-daily niacin for the treatment of dyslipidemia associated with type-2 diabetes: results of the assessment of diabetes control and evaluation of the efficacy of niaspan trial.  Arch Intern Med. 2002;162:1568-1576
PubMed   |  Link to Article
Guerios EE, Bueno RR, Nercolini DC.  et al.  Randomized comparison between inoue balloon and metallic commissurotome in the treatment of rheumatic mitral stenosis: immediate results and 6-month and 3-year follow-up.  Catheter Cardiovasc Interv. 2005;64:301-311
PubMed   |  Link to Article
Janzon M, Levin L-A, Swahn E.  et al.  Invasive treatment in unstable coronary artery disease promotes health-related quality of life: results from the FRISC II trial.  Am Heart J. 2004;148:114-121
PubMed   |  Link to Article
Koh KK, Ahn JY, Jin DK.  et al.  Effects of continuous combined hormone replacement therapy on inflammation in hypertensive and/or overweight postmenopausal women.  Arterioscler Thromb Vasc Biol. 2002;22:1459-1464
PubMed   |  Link to Article
Lee S-C, Park SW, Kim D-K.  et al.  Iron supplementation inhibits cough associated with ACE inhibitors.  Hypertension. 2001;38:166-170
PubMed   |  Link to Article
Mueller C, Buerkle G, Buettner HJ.  et al.  Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty.  Arch Intern Med. 2002;162:329-336
PubMed   |  Link to Article
Tcheng JE, Dandzari DE, Grines CL.  et al.  Benefits and risks of abciximab use in primary angioplasty for acute myocardial infarction: the controlled abciximab and device investigation to lower late angioplasty complications (CADILLAC) trial.  Circulation. 2003;108:1316-1323
PubMed   |  Link to Article
Tcheng JE, O’Shea JC, Cohen EA.  et al.  Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): a randomized, placebo-controlled trial.  Lancet. 2000;356:2037-2044
PubMed   |  Link to Article
ten Berg JM, Kelder JC, Suttorp MJ.  et al.  Influence of planned six-month follow-up angiography on late outcome after percutaneous coronary intervention: a randomized study.  J Am Coll Cardiol. 2001;38:1061-1069
PubMed   |  Link to Article
Fang JC, Kinlay S, Beltrame J.  et al.  Effect of vitamins C and E on progression of transplant-associated arteriosclerosis: a randomized trial.  Lancet. 2002;359:1108-1113
PubMed   |  Link to Article
Zhao XQ, Morse JS, Dowdy AA.  et al.  Safety and tolerability of simvastatin plus niacin in patients with coronary artery disease and low high-density lipoprotein cholesterol (The HDL atherosclerosis treatment study).  Am J Cardiol. 2004;93:307-312
PubMed   |  Link to Article
Alexander JH, Dyke CK, Yang H.  et al.  Initial experience with factor-Xa inhibition in percutaneous coronary intervention: the XaNADU-PCI pilot.  J Thromb Haemost. 2004;2:234-241
PubMed   |  Link to Article
Collins R, Armitage J, Parish S.  et al.  MRC/BHF heart protection study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial.  Lancet. 2003;361:2005-2016
PubMed   |  Link to Article
Elbaz M, Mokhtar EE, Khalife K.  et al.  Is direct coronary stenting the best strategy for long-term outcome? Results of the multicentric randomized benefit evaluation of direct coronary stenting (BET) study.  Am Heart J. 2002;144:e7
PubMed   |  Link to Article
Akhter MW, Aronson D, Bitar F.  et al.  Effect of elevated admission serum creatinine and its worsening on outcome in hospitalized patients with decompensated heart failure.  Am J Cardiol. 2004;94:957-960
PubMed   |  Link to Article
Morice M-C, Serruys PW, Sousa JE.  et al.  A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization.  N Engl J Med. 2002;346:1773-1780
PubMed   |  Link to Article
Kiessling A, Henriksson P. Efficacy of case method learning in general practice for secondary prevention in patients with coronary artery disease: randomized controlled study.  BMJ. 2002;325:877-880
PubMed   |  Link to Article
Latini R, Staszewsky L, Maggioni AP.  et al.  Beneficial effects of angiotensin-converting enzyme inhibitor and nitrate association on left ventricular remodeling in patients with large acute myocardial infarction: the delapril remodeling after acute myocardial infarction (DRAMI) trial.  Am Heart J. 2003;146:133
PubMed   |  Link to Article
Blanc J-J, De Roy L, Mansourati J.  et al.  Atrial pacing for prevention of atrial fibrillation: assessment of simultaneously implemented algorithms.  Europace. 2004;6:371-379
PubMed   |  Link to Article
Moons AH, Peters RJ, Bijsterveld NR.  et al.  Recombinant nematode anticoagulant protein c2, an inhibitor of the tissue factor/factor VIIa complex, in patients undergoing elective coronary angioplasty.  J Am Coll Cardiol. 2003;41:2147-2153i
PubMed   |  Link to Article
Klein AL, Murray D, Grimm RA.  et al.  Bleeding complications in patients with atrial fibrillation undergoing cardioversion randomized to transesophageal echocardiographically guided and conventional anticoagulation therapies.  Am J Cardiol. 2003;92:161-165
PubMed   |  Link to Article
Omran H, Schmidt H, Hackenbrock M.  et al.  Silent and apparent cerebral embolism after retrograde catheterisation of the aortic valve in valvular stenosis: a prospective, randomised study.  Lancet. 2003;361:1241-1246
PubMed   |  Link to Article
Park S-J, Lee CW, Hong M-K.  et al.  Comparison of gold-coated NIR stents with uncoated NIR stents in patients with coronary artery disease.  Am J Cardiol. 2002;89:872-875
PubMed   |  Link to Article
Pugh PJ, Jones RD, West JN.  et al.  Testosterone treatment for men with chronic heart failure.  Heart. 2004;90:446-447
PubMed   |  Link to Article
Seiler C, Pohl T, Wustmann K.  et al.  Promotion of collateral growth by granulocyte-macrophage colony-stimulating factor in patients with coronary artery disease: a randomized, double-blind, placebo-controlled study.  Circulation. 2001;104:2012-2017
PubMed   |  Link to Article
Lee CH, de Feyter P, Serruys PW.  et al.  Beneficial effects of fluvastatin following percutaneous coronary intervention in patients with unstable and stable angina: results from the Lescol Intervention Prevention Study (LIPS).  Heart. 2004;90:1156-1161
PubMed   |  Link to Article
Kini AS, Richard M, Suleman J.  et al.  Effectiveness of tirofiban, eptifibatide, and abciximab in minimizing myocardial necrosis during percutaneous coronary intervention (TEAM pilot study).  Am J Cardiol. 2002;90:526-529
PubMed   |  Link to Article
Stakos DA, Schuster DP, Sparks EA.  et al.  Long-term cardiovascular effects of insulin sensitizer troglitazone on non-diabetic individuals with insulin resistance: double blind, prospective randomized study.  J Cardiol. 2003;41:183-190
PubMed
Stone GW, Grines CL, Cox DA.  et al.  Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction.  N Engl J Med. 2002;346:957-966
PubMed   |  Link to Article
Tada H, Oral H, Knight BP.  et al.  Randomized comparison of bipolar versus unipolar plus bipolar recordings during segmental ostial ablation of pulmonary veins.  J Cardiovasc Electrophysiol. 2002;13:851-856
PubMed   |  Link to Article
Versaci F, Gaspardone A, Tomai F.  et al.  Immunosuppressive therapy for the prevention of restenosis after coronary artery stent implantation (IMPRESS study).  J Am Coll Cardiol. 2002;40:1935-1942
PubMed   |  Link to Article

Figures

Tables

Table Graphic Jump LocationeTable 2. Non–Late-Breaking Trials Included in This Study
Table Graphic Jump LocationeTable 2. Non–Late-Breaking Trials Included in This Study (cont)
Table Graphic Jump LocationeTable 2. Non–Late-Breaking Trials Included in This Study (cont)

References

Bech GJW, De Bruyne B, Pijls NHJ.  et al.  Fractional flow reserve to determine the appropriateness of angioplasty in moderate coronary stenosis: a randomized trial.  Circulation. 2001;103:2928-2934
PubMed   |  Link to Article
Bettendorf M, Schmidt KG, Grulich-Henn J.  et al.  Tri-iodothyronine treatment in children after cardiac surgery: a double-blind, randomised, placebo-controlled study.  Lancet. 2000;356:529-534
PubMed   |  Link to Article
Boden WE, van Gilst WH, Scheldewaert RG.  et al.  Diltiazem in acute myocardial infarction treated with thrombolytic agents: a randomized placebo-controlled trial.  Lancet. 2000;355:1751-1756
PubMed   |  Link to Article
Davidson CJ, Laskey WK, Hermiller JB.  et al.  Randomized trial of contrast media utilization in high-risk PTCA: the COURT trial.  Circulation. 2000;101:2172-2177
PubMed   |  Link to Article
Henkin Y, Shai I, Zuk R.  et al.  Dietary treatment of hypercholesterolemia: do dietitians do it better? a randomized, controlled trial.  Am J Med. 2000;109:549-555
PubMed   |  Link to Article
Henry TD, Annex BH, McKendall GR.  et al.  The VIVA trial: vascular endothelial growth factor in ischemia for vascular angiogenesis.  Circulation. 2003;107:1359-1365
PubMed   |  Link to Article
Hulley S, Grady D, Bush T.  et al.  Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women.  JAMA. 1998;280:605-613
PubMed   |  Link to Article
Izumi M, Tsuchikane E, Funamoto M.  et al.  Final results of the CAPAS trial.  Am Heart J. 2001;142:782-789
PubMed   |  Link to Article
Lee JK, Klein GJ, Krahn AD.  et al.  Rate-control versus conversion strategy in postoperative atrial fibrillation: a prospective, randomized pilot study.  Am Heart J. 2000;140:871-877
PubMed   |  Link to Article
Lotan C, Rozenman Y, Hendler A.  et al.  Stents in total occlusion for restenosis prevention: the multicentre randomized STOP study.  Eur Heart J. 2000;21:1960-1966
PubMed   |  Link to Article
Mahaffey KW, Harrington RA, Simoons ML.  et al.  Stroke in patients with acute coronary syndromes: incidence and outcomes in the platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial.  Circulation. 1999;99:2371-2377
PubMed   |  Link to Article
Maresta A, Balduccelli M, Varani E.  et al.  Prevention of postcoronary angioplasty restenosis by omega-3 fatty acids: main results of the espent for prevention of restentonsis Italian study (ESPRIT).  Am Heart J. 2002;143:e5
PubMed   |  Link to Article
Oesterle SN, Sanborn TA, Ali N.  et al.  Percutaneous transmyocardial laser revascularisation for severe angina: the PACIFIC randomised trial.  Lancet. 2000;356:1705-1710
PubMed   |  Link to Article
Kastrati A, Schomig A, Dirschinger J.  et al.  Increased risk of restenosis after placement of gold-coated stents: results of a randomized trial comparing gold-coated with uncoated steel stents in patients with coronary artery disease.  Circulation. 2000;101:2478-2483
PubMed   |  Link to Article
Stone GW, Moliterno DJ, Bertrand M.  et al.  Impact of clinical syndrome acuity on the differential response to 2 glycoprotein IIb/IIIa inhibitors in patients undergoing coronary stenting: the TARGET trial.  Circulation. 2002;105:2347-2354
PubMed   |  Link to Article
Vetrano A, Milani M, Corsini G. Effects of aspirin or picotamide, an antithromboxane agent, in combination with low-intensity oral anticoagulation in patients with acute myocardial infarction: a controlled randomized pilot trial.  G Ital Cardiol. 1999;29:524-528
PubMed
Anselme F, Savoure A, Cribier A.  et al.  Catheter ablation of typical atrial flutter: a randomized comparison of two methods for determining complete bidirectional isthmus block.  Circulation. 2001;103:1434-1439
PubMed   |  Link to Article
Brito FS, Caixeta AM, Perin MA.  et al.  Comparison of direct stenting versus stenting with predilation for the treatment of selected coronary narrowings.  Am J Cardiol. 2002;89:115-120
PubMed   |  Link to Article
Pedersen OD, Bagger H, Keller N.  et al.  Efficacy of dofetilide in the treatment of atrial fibrillation-flutter in patients with reduced left ventricular function.  Circulation. 2001;104:292-296
PubMed   |  Link to Article
Villani GQ, Piepoli MF, Terracciano C.  et al.  Effects of diltiazem pretreatments on direct-current cardioversion in patients with persistent atrial fibrillation: a single blind, randomized, controlled study.  Am Heart J. 2000;140:e12
Link to Article
Andrews TC, Ballantyne CM, Hsia JA.  et al.  Achieving and maintaining national cholesterol education program low-density lipoprotein cholesterol goals with five statins.  Am J Med. 2001;111:185-191
PubMed   |  Link to Article
Fiore LD, Ezekowitz MD, Brophy MT.  et al.  A randomized trial of transfer for primary angioplasty versus on-site thrombolysis in patients with high-risk myocardial infarction: primary results of the CHAMP study.  Circulation. 2002;105:557-563
PubMed   |  Link to Article
Grines CL, Westerhausen DR, Grines LL.  et al.  A randomized trial of transfer for primary angioplasty versus on-site thrombolysis in patients with high-risk myocardial infarction: the air primary angioplasty in myocardial infarction study.  J Am Coll Cardiol. 2002;39:1713-1719
PubMed   |  Link to Article
Gulielmos V, Menschikowski M, Dill H-M.  et al.  Interleukin 1, interleukin 6 and myocardial enzyme response after coronary artery bypass grafting—a prospective randomized comparison of the conventional and three minimally invasive surgical techniques.  Eur J Cardiothorac Surg. 2000;18:594-601
PubMed   |  Link to Article
Hall R, Chong C. A double-blind, parallel-group study of amlodipine versus long-acting nitrate in the management of elderly patients with stable angina.  Cardiology. 2001;96:72-77
PubMed   |  Link to Article
Peters RJG, Spickler W, Theroux P.  et al.  Randomized comparison of a novel anticoagulant, vasoflux, and heparin as adjunctive therapy to streptokinase for acute myocardial infarction: results of the VITAL study (vasoflux international trial for acute myocardial infarction lysis).  Am Heart J. 2001;142:237-243
PubMed   |  Link to Article
Reis SE, Costantino JP, Wickerham DL.  et al.  Cardiovascular effects of tamoxifen in women with and without heart disease: breast cancer prevention trial.  J Natl Cancer Inst. 2001;93:16-21
PubMed   |  Link to Article
Schuchert A, Meinertz T. A randomized study on the effects of pacemaker programming to a lower output on projected pulse generator longevity.  Pacing Clin Electrophysiol. 2001;24:1234-1239
PubMed   |  Link to Article
Sick PB, Thiele H, Brosteanu O.  et al.  Prospective randomized comparison of early and late results of 4 different stent designs.  Am Heart J. 2003;146:134-141
PubMed   |  Link to Article
Hochman JS, Buller CE, Sleeper LA.  et al.  Cardiogenic shock complicating acute myocardial infarction-etiologies, management and outcome: a report from the SHOCK trial registry.  J Am Coll Cardiol. 2000;36:1063-1070
PubMed   |  Link to Article
Tardif JC, Mercier LA, Theroux P.  et al.  Effect of inhibition of the NA+/H+ exchanger with cariporide on left ventricular function in acute coronary syndromes: results from the echocardiographic substudy of the GUARDIAN trial.  Can J Cardiol. 2004;20:317-322
PubMed
Attie F, Rosas M, Granados N.  et al.  Surgical treatment for secundum atrial septal defects in patients > 40 years old: a randomized clinical trial.  J Am Coll Cardiol. 2001;38:2035-2042
PubMed   |  Link to Article
Bech GJ, De Bruyne B, Pijls NHJ.  et al.  Fractional flow reserve to determine the appropriateness of angioplasty in moderate coronary stenosis: a randomized trial.  Circulation. 2001;103:2928-2934
PubMed   |  Link to Article
Berlowitz MS, Latif F, Hankins SR.  et al.  Dose-dependent blockade of the angiotensin II type 1 receptor with losartan in normal volunteers.  J Cardiovasc Pharmacol. 2001;37:692-696
PubMed   |  Link to Article
Brofferio A, Alaeddini J, Oommen R.  et al.  Effect of early administration of atropine on paradoxical sinus deceleration during dobutamine stress echocardiography.  Am J Cardiol. 2002;89:645-647
PubMed   |  Link to Article
Brouwer MA, van den Bergh PJ, Aengevaeren WR.  et al.  Aspirin plus coumarin versus aspirin alone in the prevention of reocclusion after fibrinolysis for acute myocardial infarction: results of the antithrombotics in the prevention of reocclusion in coronary thrombolysis (APRICOT)-2 trial.  Circulation. 2002;106:659-665
PubMed   |  Link to Article
Desmet WJ, Dens J, Coussement P.  et al.  Does adenosine prevent myocardial micronecrosis following percutaneous coronary intervention? the ADELINE pilot trial.  Heart. 2002;88:293-295
PubMed   |  Link to Article
Grines CL, Cox DA, Stone GW.  et al.  Coronary angioplasty with or without stent implantation for acute myocardial infarction.  N Engl J Med. 1999;341:1949-1956
PubMed   |  Link to Article
Grundy SM, Vega GL, McGovern ME.  et al.  Efficacy, safety, and tolerability of once-daily niacin for the treatment of dyslipidemia associated with type-2 diabetes: results of the assessment of diabetes control and evaluation of the efficacy of niaspan trial.  Arch Intern Med. 2002;162:1568-1576
PubMed   |  Link to Article
Guerios EE, Bueno RR, Nercolini DC.  et al.  Randomized comparison between inoue balloon and metallic commissurotome in the treatment of rheumatic mitral stenosis: immediate results and 6-month and 3-year follow-up.  Catheter Cardiovasc Interv. 2005;64:301-311
PubMed   |  Link to Article
Janzon M, Levin L-A, Swahn E.  et al.  Invasive treatment in unstable coronary artery disease promotes health-related quality of life: results from the FRISC II trial.  Am Heart J. 2004;148:114-121
PubMed   |  Link to Article
Koh KK, Ahn JY, Jin DK.  et al.  Effects of continuous combined hormone replacement therapy on inflammation in hypertensive and/or overweight postmenopausal women.  Arterioscler Thromb Vasc Biol. 2002;22:1459-1464
PubMed   |  Link to Article
Lee S-C, Park SW, Kim D-K.  et al.  Iron supplementation inhibits cough associated with ACE inhibitors.  Hypertension. 2001;38:166-170
PubMed   |  Link to Article
Mueller C, Buerkle G, Buettner HJ.  et al.  Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty.  Arch Intern Med. 2002;162:329-336
PubMed   |  Link to Article
Tcheng JE, Dandzari DE, Grines CL.  et al.  Benefits and risks of abciximab use in primary angioplasty for acute myocardial infarction: the controlled abciximab and device investigation to lower late angioplasty complications (CADILLAC) trial.  Circulation. 2003;108:1316-1323
PubMed   |  Link to Article
Tcheng JE, O’Shea JC, Cohen EA.  et al.  Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): a randomized, placebo-controlled trial.  Lancet. 2000;356:2037-2044
PubMed   |  Link to Article
ten Berg JM, Kelder JC, Suttorp MJ.  et al.  Influence of planned six-month follow-up angiography on late outcome after percutaneous coronary intervention: a randomized study.  J Am Coll Cardiol. 2001;38:1061-1069
PubMed   |  Link to Article
Fang JC, Kinlay S, Beltrame J.  et al.  Effect of vitamins C and E on progression of transplant-associated arteriosclerosis: a randomized trial.  Lancet. 2002;359:1108-1113
PubMed   |  Link to Article
Zhao XQ, Morse JS, Dowdy AA.  et al.  Safety and tolerability of simvastatin plus niacin in patients with coronary artery disease and low high-density lipoprotein cholesterol (The HDL atherosclerosis treatment study).  Am J Cardiol. 2004;93:307-312
PubMed   |  Link to Article
Alexander JH, Dyke CK, Yang H.  et al.  Initial experience with factor-Xa inhibition in percutaneous coronary intervention: the XaNADU-PCI pilot.  J Thromb Haemost. 2004;2:234-241
PubMed   |  Link to Article
Collins R, Armitage J, Parish S.  et al.  MRC/BHF heart protection study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial.  Lancet. 2003;361:2005-2016
PubMed   |  Link to Article
Elbaz M, Mokhtar EE, Khalife K.  et al.  Is direct coronary stenting the best strategy for long-term outcome? Results of the multicentric randomized benefit evaluation of direct coronary stenting (BET) study.  Am Heart J. 2002;144:e7
PubMed   |  Link to Article
Akhter MW, Aronson D, Bitar F.  et al.  Effect of elevated admission serum creatinine and its worsening on outcome in hospitalized patients with decompensated heart failure.  Am J Cardiol. 2004;94:957-960
PubMed   |  Link to Article
Morice M-C, Serruys PW, Sousa JE.  et al.  A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization.  N Engl J Med. 2002;346:1773-1780
PubMed   |  Link to Article
Kiessling A, Henriksson P. Efficacy of case method learning in general practice for secondary prevention in patients with coronary artery disease: randomized controlled study.  BMJ. 2002;325:877-880
PubMed   |  Link to Article
Latini R, Staszewsky L, Maggioni AP.  et al.  Beneficial effects of angiotensin-converting enzyme inhibitor and nitrate association on left ventricular remodeling in patients with large acute myocardial infarction: the delapril remodeling after acute myocardial infarction (DRAMI) trial.  Am Heart J. 2003;146:133
PubMed   |  Link to Article
Blanc J-J, De Roy L, Mansourati J.  et al.  Atrial pacing for prevention of atrial fibrillation: assessment of simultaneously implemented algorithms.  Europace. 2004;6:371-379
PubMed   |  Link to Article
Moons AH, Peters RJ, Bijsterveld NR.  et al.  Recombinant nematode anticoagulant protein c2, an inhibitor of the tissue factor/factor VIIa complex, in patients undergoing elective coronary angioplasty.  J Am Coll Cardiol. 2003;41:2147-2153i
PubMed   |  Link to Article
Klein AL, Murray D, Grimm RA.  et al.  Bleeding complications in patients with atrial fibrillation undergoing cardioversion randomized to transesophageal echocardiographically guided and conventional anticoagulation therapies.  Am J Cardiol. 2003;92:161-165
PubMed   |  Link to Article
Omran H, Schmidt H, Hackenbrock M.  et al.  Silent and apparent cerebral embolism after retrograde catheterisation of the aortic valve in valvular stenosis: a prospective, randomised study.  Lancet. 2003;361:1241-1246
PubMed   |  Link to Article
Park S-J, Lee CW, Hong M-K.  et al.  Comparison of gold-coated NIR stents with uncoated NIR stents in patients with coronary artery disease.  Am J Cardiol. 2002;89:872-875
PubMed   |  Link to Article
Pugh PJ, Jones RD, West JN.  et al.  Testosterone treatment for men with chronic heart failure.  Heart. 2004;90:446-447
PubMed   |  Link to Article
Seiler C, Pohl T, Wustmann K.  et al.  Promotion of collateral growth by granulocyte-macrophage colony-stimulating factor in patients with coronary artery disease: a randomized, double-blind, placebo-controlled study.  Circulation. 2001;104:2012-2017
PubMed   |  Link to Article
Lee CH, de Feyter P, Serruys PW.  et al.  Beneficial effects of fluvastatin following percutaneous coronary intervention in patients with unstable and stable angina: results from the Lescol Intervention Prevention Study (LIPS).  Heart. 2004;90:1156-1161
PubMed   |  Link to Article
Kini AS, Richard M, Suleman J.  et al.  Effectiveness of tirofiban, eptifibatide, and abciximab in minimizing myocardial necrosis during percutaneous coronary intervention (TEAM pilot study).  Am J Cardiol. 2002;90:526-529
PubMed   |  Link to Article
Stakos DA, Schuster DP, Sparks EA.  et al.  Long-term cardiovascular effects of insulin sensitizer troglitazone on non-diabetic individuals with insulin resistance: double blind, prospective randomized study.  J Cardiol. 2003;41:183-190
PubMed
Stone GW, Grines CL, Cox DA.  et al.  Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction.  N Engl J Med. 2002;346:957-966
PubMed   |  Link to Article
Tada H, Oral H, Knight BP.  et al.  Randomized comparison of bipolar versus unipolar plus bipolar recordings during segmental ostial ablation of pulmonary veins.  J Cardiovasc Electrophysiol. 2002;13:851-856
PubMed   |  Link to Article
Versaci F, Gaspardone A, Tomai F.  et al.  Immunosuppressive therapy for the prevention of restenosis after coronary artery stent implantation (IMPRESS study).  J Am Coll Cardiol. 2002;40:1935-1942
PubMed   |  Link to Article
CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.